Optimizing neoral therapeutic drug monitoring with cyclosporine trough (C 0 ) and C 2 concentrations in stable renal allograft recipients

By Einecke G.   Mai I.   Diekmann F.   Fritsche L.   Boehler T.   Neumayer H.-H.   Budde K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3102-3103

Elsevier

Access to resources Recommend Favorite

Neoral (cyclosporine) C 2 monitoring in renal transplant recipients: a single-center experience in Asia

By Wong H.-S.   Morad Z.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 230-231

Elsevier

Access to resources Recommend Favorite

Single-center study utilizing C 2 level as monitoring tool in de novo renal transplant recipients treated with neoral

By Keshavamurthy M.   Al Ahmadi I.   Mohammed Raza S.   Baynton R.   Al Meshari K.   Al Shaibani K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3112-3114

Elsevier

Access to resources Recommend Favorite

Neoral C 2 monitoring in pediatric liver transplant recipients

By Dunn S.   Falkenstein K.   Cooney G.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3094-3095

Elsevier

Access to resources Recommend Favorite

Neoral drug monitoring in stable kidney allotransplant recipients: C 0 versus C 2

By Lukaschek J.   Hofmann J.   Aerne D.   Ambuhl P.   Kistler T.   Knoflach A.   Pei P.   Binswanger U.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3104-3105

Elsevier

Access to resources Recommend Favorite